Reduced serum levels of syndecan-1 in patients with tongue squamous cell carcinoma. (Q40211948)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26667395%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

Reduced serum levels of syndecan-1 in patients with tongue squamous cell carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26667395%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26667395%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26667395%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26667395%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Mohammad Sohrabi Shegefti

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26667395%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Zahra Malek-Hosseini

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26667395%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Bijan Khademi

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26667395%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

language of work or name

English

0 references

publication date

15 December 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26667395%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26667395%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

126

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26667395%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26667395%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

E191-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26667395%20AND%20SRC:MED&resulttype=core&format=json

Predictive model of oral cancer metastasis for different cancer sites and age groups

2 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

Metastasis of squamous cell carcinoma of the oral tongue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

The effects of hyperosmosis or high pH on a dual‐species biofilm of Enterococcus faecalis and Pseudomonas aeruginosa: an in vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

Different mechanisms of syndecan-1 activation through a fibroblast-growth-factor-inducible response element (FiRE) in mucosal and cutaneous wounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

Correlation between reduction of syndecan-1 expression and clinico-pathological parameters in squamous cell carcinoma of tongue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

Reduction of syndecan-1 expression is associated with dysplastic oral epithelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

Induced expression of syndecan in healing wounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

Syndecan-1 expression has prognostic significance in head and neck carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

Immunohistochemical expression of syndecan-1 in oral dysplastic epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

Novel processed form of syndecan-1 shed from SCC-9 cells plays a role in cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

Clinical implications in the shift of syndecan-1 expression from the cell membrane to the cytoplasm in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

Shed syndecan-1 translocates to the nucleus of cells delivering growth factors and inhibiting histone acetylation: a novel mechanism of tumor-host cross-talk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

Oxidative stress alters syndecan-1 distribution in lungs with pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

Soluble CD138/Syndecan-1 Increases in the Sera of Patients with Moderately Differentiated Bladder Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

Soluble syndecan-1 promotes growth of myeloma tumors in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

Molecular functions of syndecan-1 in disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

Proteoglycans in health and disease: the multiple roles of syndecan shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

Specific syndecan-1 domains regulate mesenchymal tumor cell adhesion, motility and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

TNM staging of cancers of the head and neck: striving for uniformity among diversity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

Tumor cell adhesion to the extracellular matrix and signal transduction mechanisms implicated in tumor cell motility, invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

Syndecans shed their reputation as inert molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

Defects in keratinocyte activation during wound healing in the syndecan-1-deficient mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1/CXCL12 and mediated by the matrix metalloproteinase-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

MMP7 shedding of syndecan-1 facilitates re-epithelialization by affecting alpha(2)beta(1) integrin activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

Cancer-associated fibroblasts and epithelial-mesenchymal transition in metastatic oral tongue squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

Tissue transglutaminase is a negative regulator of monomeric lacritin bioactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

Restricted epithelial proliferation by lacritin via PKCalpha-dependent NFAT and mTOR pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

Immunoreactivity to cell surface syndecans in cytoplasm and nucleus: tubulin-dependent rearrangements

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

Syndecans as modulators and potential pharmacological targets in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.25812

21 January 2018

Identifiers

DOI

10.1002/LARY.25812

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26667395%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26667395%20AND%20SRC:MED&resulttype=core&format=json